[ T able_StockInfo] 2026 年 03 月 18 日 证券研究报告•2025 年年报点评 当前价：13.72 港元 康哲药业（0867.HK）医疗保健 目标价：——港元 业绩重回增长轨道，增长动能全面焕新 | 指标/年度 | 2025A | 2026E | 2027E | 2028E | | --- | --- | --- | --- | --- | | 营业收入(百万元) | 8212.06 | 9492.32 | 11409.77 | 13725.95 | | 增长率 | 9.95% | 15.59% | 20.20% | 20.30% | | 归属母公司净利润(百万元) | 1488.89 | 1968.28 | 2370.01 | 2837.76 | | 增长率 | -8.08% | 32.20% | 20.41% | 19.74% | | 每股收益 EPS | 0.61 | 0.81 | 0.97 | 1.16 | | 净资产收益率 | 8.56% | 10.16% | 10.90% | 11.55% | | PE | 19.76 | 14.95 | 12.42 | 10.37 ...

Investment Rating - The report maintains an "Outperform" rating for the machinery equipment industry [1]. Core Insights - The robotics index underperformed the market, with a decline of 2.3%, lagging behind the Shanghai Composite Index by 1.6 percentage points and the CSI 300 Index by 2.5 percentage points during the week of March 9 to March 15, 2026 [5][12]. - The AWE2026 showcased numerous robotics manufacturers, including Tesla's humanoid robot, highlighting advancements in robotics technology and product launches [5][16]. - Figure's new robot, Figure 03, demonstrated full autonomy in cleaning tasks, showcasing significant advancements in robotics capabilities without the need for new algorithms [5][18][23]. - Guanglun Intelligent announced a successful financing round of 1 billion yuan, becoming the first unicorn in the field of embodied data, with plans to enhance its physical AI data and simulation infrastructure [5][25]. Summary by Sections Market Review - The robotics index experienced a 2.3% decline, underperforming compared to major indices [5][12]. - Specific robotics companies showcased new products at AWE2026, indicating a vibrant market with innovative solutions [5][16]. Industry Dynamics - The AWE2026 event highlighted the presence of key robotics manufacturers and the introduction of new products aimed at various applications, including elder care and home assistance [5][16]. - Figure 03's capabilities in autonomous cleaning tasks represent a significant leap in robotics technology, emphasizing the potential for household applications [5][18][23]. - Guanglun Intelligent's financing success positions it as a leader in the physical AI data sector, with a focus on research and development [5][25].

1. Report's Industry Investment Rating No information provided in the content. 2. Core Views of the Report - The interest rate curve may still have room to steepen. The bond market remains in a pattern where the short - end is supported by loose liquidity and the long - end lacks a clear downward driver. The probability of the interest rate curve continuing to steepen is relatively high, and the performance of the medium - short end may be better than that of the long - end. The strategy is to maintain the portfolio duration in the range of 3 - 5 years and pay attention to trading opportunities brought by the phased fluctuations of long - end interest rates [2][87] - The implementation of the inter - bank self - regulatory "patch" is expected to reduce the bank's liability cost by about 1 - 2BP, which is a marginal positive for short - term liquid assets in terms of asset allocation and fund flow. It also helps to ease the pressure on the bank's liabilities and create space for the subsequent easing of monetary policy [1][85] 3. Summary According to the Directory 3.1 Important Matters - On March 16, 2026, the central bank carried out 5000 billion yuan of 6 - month (182 - day) outright reverse repurchase operations, with a net withdrawal of 1000 billion yuan. As of March 16, the outstanding scale of 6 - month outright reverse repurchase was 4.4 trillion yuan [7] - Starting from March 12, some member banks were required to strengthen self - management, and the proportion of inter - bank demand deposits higher than the 7 - day OMO policy rate at the end of the quarter should not exceed 10% - 20%. This is an upgrade of the self - regulatory management in late 2024 [10] - From January to February 2026, the cumulative increase in social financing scale was 9.6 trillion yuan, 316.2 billion yuan more than the same period of the previous year. The increase in RMB loans to the real economy was 5.75 trillion yuan, 124.8 billion yuan less than the same period of the previous year [11] 3.2 Money Market 3.2.1 Open Market Operations and Fund Rate Trends - From March 9 to March 13, 2026, the central bank's 7 - day reverse repurchase operations had a net withdrawal of 101.1 billion yuan. From March 16 to March 20, the central bank is expected to withdraw 176.5 billion yuan of base currency [15] - In the second week of March, the central bank continued to withdraw base currency through short - term reverse repurchases, and market interest rates rose. DR001 remained above 1.3% during the week. As of March 13, R001, R007, DR001, and DR007 were 1.392%, 1.503%, 1.322%, and 1.462% respectively [21] 3.2.2 Certificate of Deposit (CD) Rate Trends and Repurchase Transaction Volume - Last week, the issuance scale of inter - bank CDs was 846.34 billion yuan, with a net financing scale of - 161.86 billion yuan. The institution with the largest CD issuance scale was joint - stock banks, with a net financing scale of 37.47 billion yuan [23][27] - The issuance interest rates of inter - bank CDs decreased last week. The average issuance interest rates of 3 - month and 1 - year CDs of state - owned banks decreased by 1.88BP and 0.67BP respectively. The average issuance interest rates of 3 - month and 1 - year CDs of joint - stock banks decreased by 3.06BP and 0.97BP respectively [29] - Affected by the implementation of the inter - bank demand deposit self - regulatory 2.0 version, the yields of inter - bank CDs with a term of more than 6 months declined significantly, and the term spread of CDs further narrowed [30] 3.3 Bond Market 3.3.1 Primary Market - Last week, the number of interest - rate bond issuances was 58, with an actual issuance amount of 681.545 billion yuan, a maturity amount of 426.318 billion yuan, and a net financing amount of 255.227 billion yuan. In 2026, the issuance rhythm of national bonds was slightly behind that of local bonds [33] - As of March 13, 2026, the cumulative net financing scale of national bonds was about 0.83 trillion yuan, and that of local bonds was about 2.13 trillion yuan. The issuance scales of both were higher than the average levels of the same period from 2022 - 2025 [33] - As of last week, the issuance scale of special refinancing bonds was 0.88 trillion yuan, and the issuance terms were mainly long - term and ultra - long - term. The regions with relatively large issuance scales were Jiangsu, Inner Mongolia, Zhejiang, Hunan, and Henan [42] 3.3.2 Secondary Market - Last week, the bond market showed a volatile upward trend. On the day when the inter - bank demand deposit self - regulatory 2.0 version was implemented, the bond market rose across the board, but gave back the gains the next day. The curve shape steepened [33] - The yields of 1 - year, 3 - year, 5 - year, 7 - year, 10 - year, and 30 - year national bonds changed by - 0.50BP, 0.75BP, 2.78BP, 3.71BP, 3.33BP, and 8.53BP respectively. The 10Y - 1Y national bond maturity yield spread widened from 49.52BP to 53.75BP [44] - The average trading volume of the 10 - year national bond active bond (250016) increased by about 20.18% last week, and the average turnover rate increased by about 0.94 percentage points. The average trading volume of the 10 - year CDB active bond (250220) decreased by about 10.67%, and the average turnover rate decreased by about 15.39 percentage points [46] 3.4 Institutional Behavior Tracking - Supported by abundant liquidity, the scale of leveraged trading remained high last week. Large banks began to replenish 5 - 10 - year national bonds, small and medium - sized banks began to increase their holdings of national bonds over 10 years and 5 - 10 - year policy - financial bonds, insurance companies increased their buying efforts, securities companies sold large - scale, and funds still preferred policy - financial bonds with a term of less than 5 years [60][68] - In January 2026, the leverage ratio of all institutions in the inter - bank market was about 119.30%, a decrease of about 0.07 percentage points compared with December 2025. The leverage ratios of commercial banks, securities companies, and other institutions were about 111.11%, 191.81%, and 132.51% respectively [60] 3.5 High - Frequency Data Tracking - Last week, the settlement price of rebar futures increased by 5.97% week - on - week, the settlement price of wire rod futures decreased by 5.71% week - on - week, the settlement price of cathode copper futures increased by 2.04% week - on - week, the cement price index decreased by 0.37% week - on - week, and the Nanhua Glass Index increased by 2.02% week - on - week [83] - The CCFI index decreased by 4.00% week - on - week, and the BDI index increased by 4.75% week - on - week. The wholesale price of pork decreased by 2.53% week - on - week, and the wholesale price of vegetables decreased by 5.02% week - on - week [83] - The settlement prices of Brent crude oil futures and WTI crude oil futures decreased by 1.41% and 1.78% respectively week - on - week. The central parity rate of the US dollar against the RMB was 6.92 last week [83] 3.6 Market Outlook - The implementation of the inter - bank self - regulatory "patch" will further reduce the high - interest inter - bank liabilities of banks, and banks may face the need to replenish liabilities in the short term. Non - bank institutions may increase their allocation of alternative assets and increase repurchase investments, which is positive for the short - term capital market. It also helps to ease the pressure on bank liabilities and create space for the subsequent easing of monetary policy [1][85] - The interest rate curve may still have room to steepen. The bond market remains in a pattern where the short - end is supported by loose liquidity and the long - end lacks a clear downward driver. The strategy is to maintain the portfolio duration in the range of 3 - 5 years and pay attention to trading opportunities brought by the phased fluctuations of long - end interest rates [2][87]

1. Report Industry Investment Rating No information provided in the content. 2. Core Viewpoints of the Report - Last week, the bond market showed weak oscillations, and the scale of the bond ETF market shrank. The net inflows of interest - rate bond ETFs, credit - bond ETFs, and convertible - bond ETFs were -3.276 billion yuan, -4.829 billion yuan, and -1.699 billion yuan respectively, with a total net inflow of -9.804 billion yuan in the bond ETF market. The release of February CPI and foreign trade data, along with geopolitical conflicts, led to inflation concerns and a weak bond market [2][5]. - In the short term, short - term assets are expected to remain dominant due to strengthened inter - bank deposit self - regulation and quarter - end disturbances. If the inter - bank demand deposit rate is reduced, non - bank institutions may accelerate "deposit substitution", boosting the short - term allocation value of short - duration products like short - term financing ETFs. For long - term products, the macro - economic fundamentals are in a "weak recovery" state, and the long - term interest - rate bond ETFs may face difficulties in yield decline. At the quarter - end, there is a marginal tightening of funds, and some bond ETFs may face redemption tests [2][7]. - It is recommended to be cautious about extending the duration and pay attention to credit - bond ETFs with stable coupons and liquidity advantages. There may be arbitrage opportunities in some benchmark - making and science - innovation bond ETFs with significant secondary - market discounts. For convertible - bond ETFs, although the share decreased slightly last week, there is still expansion potential after the "Two Sessions" policies are implemented [2][7]. 3. Summary According to the Directory 3.1 各类债券 ETF 资金净流入情况 - The bond ETF market scale shrank last week. The net inflows of interest - rate bond ETFs, credit - bond ETFs, and convertible - bond ETFs were -3.276 billion yuan, -4.829 billion yuan, and -1.699 billion yuan respectively, with a total net inflow of -9.804 billion yuan. As of March 13, 2026, the bond ETF fund scale was 726.096 billion yuan, down 1.54% from the previous week and 12.44% from the beginning of the year, accounting for 13.82% of the total ETF scale, a decrease of 9 basis points from the previous weekend [5]. - Short - term financing ETFs had a large net inflow of 2.183 billion yuan last week, followed by urban investment bond ETFs and corporate bond ETFs with net inflows of 727 million yuan and 192 million yuan respectively. Science - innovation bond ETFs and benchmark - making credit - bond ETFs had large net outflows, mainly due to deep discounts in the secondary market. Treasury - bond ETFs also had a large net outflow [6]. 3.2 各类债券 ETF 份额走势 - As of March 13, 2026, the shares of treasury - bond, policy - financial - bond, local - bond, benchmark - making credit - bond, science - innovation bond, corporate - bond, short - term financing, urban - investment - bond, and convertible - bond ETFs were 608.04 million shares, 353.12 million shares, 160.66 million shares, 993.44 million shares, 2646.27 million shares, 338.41 million shares, 723.05 million shares, 3294.68 million shares, and 5598.95 million shares respectively, with changes of -3.8%, -1.1%, 0.4%, -3.1%, -1.9%, 0.5%, 2.7%, 2.2%, and -2.1% compared to March 6, 2026, and the total change of bond - type ETF shares was -0.9% [18]. 3.3 各基准做市信用债 ETF 份额及净值走势 - The shares of existing credit - bond ETFs generally declined. As of March 13, 2026, the shares of 8 credit - bond ETFs were 99.46 million shares, 85.41 million shares, 103.54 million shares, 96.47 million shares, 174.83 million shares, 203.50 million shares, 93.00 million shares, and 141.32 million shares respectively, with changes of -3.87%, -3.39%, no change, no change, no change, -7.58%, -0.96%, and -2.08% compared to March 6, 2026 [19]. - The net - value growth of credit - bond ETFs slowed down. As of March 13, 2026, the net values of 8 credit - bond ETFs were 1.0207, 1.0198, 1.0182, 1.0185, 1.0134, 1.0164, 1.0174, and 1.0164 respectively, with changes of 0.02%, 0.01%, 0.01%, 0.01%, no change, no change, -0.01%, and -0.01% compared to March 6, 2026, and changes of 0.14%, 0.13%, 0.12%, 0.12%, 0.11%, 0.11%, 0.11%, and 0.11% compared to the end of last month [21]. 3.4 各科创债 ETF 份额及净值走势 - The science - innovation bond ETFs experienced net redemptions. The total net inflow of shares last week was -46.01 million shares, a decrease of 1.71% from the previous week. The top three products in terms of share size were Science - innovation Bond ETF Jiashi, Science - innovation Bond ETF Yinhua, and Science - innovation Bond ETF Penghua, with 214.54 million shares, 198.49 million shares, and 191.81 million shares respectively. The top three products with net outflows were Science - innovation Bond ETF Jiashi, Science - innovation Bond ETF Yifangda, and Science - innovation Bond ETF Penghua, with net outflows of 12.18 million shares, 12.00 million shares, and 5.00 million shares respectively [26]. - The net - value growth of science - innovation bond ETFs significantly narrowed. As of March 13, 2026, the top - ranked products in terms of net value were Science - innovation Bond ETF Wanjia, Science - innovation ETF Huatai Bairui, and Science - innovation Bond ETF Yongying, with net values of 1.0103, 1.0100, and 1.0099 respectively. The median net values of the first - batch and second - batch science - innovation bond ETFs were 1.0058 and 1.0084 respectively, with no change compared to the previous week. The median net values of products tracking the CSI AAA Science - innovation Bond Index, Shanghai AAA Science - innovation Bond Index, and Shenzhen AAA Science - innovation Bond Index were 1.0079, 1.0063, and 1.0101 respectively, with changes of -0.01%, 0.00%, and +0.01% compared to the previous week [31]. 3.5 上周单只债券 ETF 市场表现情况 - Most bond ETF products had a decline in net value. The 30 - year Treasury Bond ETF, 30 - year ETF Boshi, and Convertible Bond ETF Haifutong led the decline, with decreases of 1.49%, 1.44%, and 1.14% respectively compared to the previous week. In terms of premium/discount rates, the Corporate Bond ETF, Treasury Bond ETF Huaxia, and Urban Investment Bond ETF Haifutong had the highest premium rates, at +0.02%, +0.02%, and +0.02% respectively. In terms of scale changes, the Short - term Financing ETF Haifutong had the largest net inflow of 2.183 billion yuan, while the 30 - year Treasury Bond ETF, Corporate Bond ETF Yifangda, and Convertible Bond ETF Boshi had the largest net outflows, at -1.762 billion yuan, -1.696 billion yuan, and -1.384 billion yuan respectively [32]. 3.6 基准做市信用债和科创债 ETF 的 PCF 清单边际变化 - For benchmark - making credit - bond ETFs, the PCF lists of Corporate Bond ETF Nanfang and Credit - Bond ETF Haifutong added 12 and 15 bonds respectively, with average modified durations of 3.33 years and 3.94 years. The bond "25 Jingtou K2" was repeatedly included in the PCF lists of benchmark - making credit - bond ETFs, with a modified duration of 4.0323 years [35]. - For science - innovation bond ETFs, the newly included bonds of Science - innovation Bond ETF Morgan, Science - innovation Bond ETF Tianhong, and Science - innovation Bond ETF Nanfang had relatively large average durations of 8.85 years, 8.85 years, and 8.50 years respectively. The average modified duration of the bonds removed from the PCF list of Science - innovation Bond ETF Tianhong, which tracks the CSI AAA Science - innovation Bond Index, was significantly longer at 7.30 years. Ten bonds such as "23 Sichuan Investment K1" were repeatedly removed from the PCF lists of science - innovation bond ETFs, and seven bonds such as "24 Sichuan Investment K1" were included in multiple science - innovation bond ETFs [36][39]. 3.7 债券 ETF 基金运营管理规则变更汇总 - On March 12, 2026, Credit - Bond ETF Dacheng changed the cash - substitution flag of the PCF list to "must". On March 13, 2026, Credit - Bond ETF Guangfa and Corporate Bond ETF Yifangda also made the same change. On March 11 and March 13, 2026, Science - innovation Bond ETF China Merchants and Science - innovation Bond ETF Yifangda changed the cash - substitution flag of the PCF list to "must" respectively [41].

Financing Trends - In February 2026, the total social financing (社融) stock grew by 8.2% year-on-year, maintaining the same growth rate as January[1] - The incremental social financing in February 2026 was 23,792 billion RMB, an increase of 1,461 billion RMB year-on-year, marking the second consecutive month of year-on-year growth[1] - The issuance of RMB loans to the real economy increased by 8,484 billion RMB in February 2026, up 1,956 billion RMB year-on-year, indicating a return to year-on-year growth[1] Corporate and Government Financing - Corporate loans increased by 14,900 billion RMB in February 2026, up 4,500 billion RMB year-on-year, reflecting enhanced corporate credit willingness[2] - Government bond financing in February 2026 was 14,036 billion RMB, a decrease of 2,903 billion RMB year-on-year, primarily due to base effects from the previous year[1] - Direct financing saw a new addition of 16,000 billion RMB, down 2,706 billion RMB year-on-year, largely impacted by government bond financing[1] Household Financing and Deposits - Household loans decreased by 6,507 billion RMB in February 2026, down 2,616 billion RMB year-on-year, influenced by the timing of the Spring Festival[2] - RMB deposits increased by 11,700 billion RMB in February 2026, but this represented a decrease of 32,500 billion RMB year-on-year[4] - M1 growth rate rose to 5.9%, an increase of 1 percentage point, attributed to strong foreign exchange settlements by export enterprises[4] Economic Outlook - The government set a GDP growth target of 4.5%-5% for 2026, aiming for better outcomes in practice[1] - The monetary policy remains "moderately loose," consistent with the previous year's economic work conference, with an increased focus on "reasonable price recovery"[1]

Investment Rating - The report assigns a neutral investment rating to the company, indicating that the stock is expected to perform in line with the market over the next six months [17]. Core Insights - The company's performance met expectations, with total revenue for 2025 reaching $548.51 million, a decrease of 12.96% year-over-year. The net profit attributable to the parent company was $456.91 million, reflecting a significant increase of 1111.03% [2][7]. - The ATTC platform has entered the clinical trial phase, representing a potential breakthrough in cancer precision therapy. The first candidate drug, HMPL-A251, is set to begin clinical trials in December 2025, with additional candidates expected to follow [7]. - The oncology/immunology business segment is projected to generate revenues of $3.3 to $4.5 billion in 2026, with significant contributions from various products [7]. Financial Projections - Revenue forecasts for 2026, 2027, and 2028 are estimated at $648.34 million, $728.09 million, and $847.49 million, respectively, with growth rates of 18.20%, 12.30%, and 16.40% [2][10]. - The net profit for 2026 is projected to drop to $4.02 million, followed by a recovery to $5.83 million in 2027 and $6.73 million in 2028 [2][10]. - Earnings per share (EPS) are expected to be $0.00 in 2026, with a slight increase to $0.01 in 2027 and 2028 [2][10]. Product Performance - The oncology product sales reached $520 million in 2025, with specific contributions from various drugs: - Furmonertinib (呋喹替尼) sales in the U.S. were $370 million (+26%), while in China, they were $100 million (-13%) - Other products like Savolitinib (赛沃替尼) and Sunitinib (索凡替尼) contributed $27 million and $28.9 million, respectively [7]. - The company aims to seek collaboration opportunities with multinational pharmaceutical companies for the development of ATTC candidate drugs in 2026 [7].

Investment Rating - The report assigns a "Buy" rating for the company, indicating an expected relative price increase of over 20% in the next six months [15]. Core Insights - The company is enhancing its universal CAR-T product portfolio, with the in vivo CAR-T expected to initiate clinical trials in 2026. The proprietary platforms, THANK-uCAR® and THANK-u Plus®TM, are being utilized to develop differentiated universal CAR-T cell products [2][3]. - The company reported a revenue of 1.3 billion yuan in 2025, with a net loss of 1 billion yuan, a significant reduction from the previous year's loss of 8 billion yuan. As of December 31, 2025, cash and cash equivalents stood at 1.12 billion yuan [8]. - The company has received 218 orders for its product, Sikeizai®, from East China Pharmaceutical in 2025 and has been included in the "Commercial Health Insurance Innovative Drug Directory" [8]. Financial Projections - Revenue projections for the company are as follows: 2.6 billion yuan in 2026, 4.9 billion yuan in 2027, and 8 billion yuan in 2028, driven by the commercialization of CT053 and CT041 [10][11]. - The company anticipates a significant increase in net profit, projecting a profit of 63.26 million yuan in 2027 and 249.58 million yuan in 2028, following a net loss of 97.86 million yuan in 2025 [3][11]. - Earnings per share (EPS) are expected to improve from -0.17 yuan in 2025 to 0.43 yuan in 2028, reflecting the anticipated growth in profitability [3][11]. Product Development - The company is advancing multiple universal CAR-T products targeting various antigens, including CT0596 (BCMA) and CT1190B (CD19/CD20), with initial data expected to be presented at the ASH conference in December 2025 [2]. - The in vivo CAR-T candidate, KJ-C2529, targeting CD19/CD20 for B-cell lymphoma, is set to begin clinical trials in 2026 [2].

Investment Rating - The report maintains an "Outperform" rating for the machinery equipment industry [1]. Core Insights - The machinery equipment industry is experiencing sustained growth, with February exports exceeding expectations. The main drivers are the "replacement cycle and external demand" [1][6]. - Domestic sales of excavators slightly decreased in January-February 2026, while exports continued to grow significantly. The overall upward trend for the year remains unchanged despite short-term fluctuations due to the Spring Festival [6]. Summary by Sections Market Review - In February 2026, the Shenwan Machinery Index rose approximately 7.35%, outperforming the Shanghai Composite Index by 6.26 percentage points and the CSI 300 by 7.26 percentage points [13]. - The performance of different segments includes: - Complete machine manufacturing for earthmoving/concrete/lifting machinery: -1.7% - Complete machine manufacturing for others: 2.5% - Components: 20.7% [13]. Industry Tracking - Excavator sales in January-February 2026 totaled 35,934 units, a year-on-year increase of 13.10%. Domestic sales were 15,478 units, down 9.19%, while exports reached 20,456 units, up 38.8% [18]. - Loader sales for the same period were 21,299 units, a year-on-year increase of 27.9%. Domestic sales were 9,156 units, up 11.5%, and exports were 12,143 units, up 43.9% [18]. Macro Dynamics - In February 2026, the manufacturing PMI fell to 49.0%, indicating a seasonal decline. However, high-tech manufacturing PMI remains in the expansion zone at 51.5% [48]. - The government has clarified its fiscal strategy, planning to issue 4.4 trillion yuan in special bonds and 800 billion yuan in ultra-long-term special bonds to support large-scale equipment updates [48]. Key Targets - Recommended leading manufacturers include: - Zoomlion Heavy Industry (000157) - Sany Heavy Industry (600031) - XCMG (000425) - LiuGong (000528) [6]. - Core component manufacturers to focus on: - Hengli Hydraulic (601100) - Aidi Precision (603638) - Fushite (301446) [6].

Core Insights - The global defense spending is projected to reach $2.63 trillion in 2025, a 2.5% increase year-on-year, with defense spending as a percentage of global GDP rising from 1.89% to 2.01% [4] - China's defense budget for 2026 is set at 1.91 trillion yuan, reflecting a 7% increase from 2025, indicating a stable growth trajectory [4][36] - The upcoming 2027 milestone for China's military development will likely accelerate industry growth and equipment development [4][39] - The military-civilian integration and military trade are expected to open new market opportunities for defense companies [4][6] Section 1: Military Investment Growth - The report highlights the increasing military expenditures by various countries in response to global uncertainties and conflicts, with the U.S. defense budget for 2026 at $901 billion [4][34] - China's defense spending growth remains robust, with a 7% increase planned for 2026, maintaining a long-term upward trend [4][36] - The emphasis on achieving the centenary military goals by 2027 will drive new momentum in the defense sector [4][39] Section 2: Recommended Sectors - Key sectors to focus on include military technology for civilian use, military trade, and low-cost weaponry [6][42] - The commercial aerospace sector is expected to benefit from advancements in military aircraft development, with significant progress in the C919 program [42][44] - The military trade market is anticipated to experience rapid growth due to ongoing international conflicts [6][73] Section 3: Historical Performance and Future Outlook - The military industry has seen fluctuating performance, with a notable recovery in revenue and profit margins since 2025, driven by the end of previous disruptions [14][28] - The defense sector's revenue for Q1-Q3 2025 reached 540.57 billion yuan, a 16.2% year-on-year increase, indicating a positive trend [14][28] - The report suggests that the military industry will continue to recover and grow, supported by domestic demand and military trade opportunities [14][28] Section 4: Inventory and Order Demand - The military sector's inventory increased significantly, with total inventory reaching 366.65 billion yuan by Q3 2025, reflecting strong downstream order demand [21][24] - Prepayments and contract liabilities surged to 405.88 billion yuan, indicating a robust order pipeline [21][24] - The report emphasizes the correlation between inventory levels and order demand, suggesting a positive outlook for future revenue [21][24] Section 5: Cash Flow and Financial Health - The operating cash flow for the military industry showed improvement, with a net cash flow of -30.11 billion yuan for Q1-Q3 2025, an improvement from the previous year [28] - The long cash conversion cycle in the military sector continues to pose challenges, but the situation is expected to improve as previous disruptions are resolved [28]

Investment Rating - The report indicates a positive investment outlook for the storage industry, highlighting a "super growth cycle" driven by explosive demand and rigid supply conditions [1][3]. Core Insights - The storage industry is entering a super cycle due to the unexpected iteration and upgrade of AI large model technology, leading to an explosive increase in global token consumption and a massive demand for data storage, processing, and retrieval [3][4]. - Major overseas manufacturers are shifting limited production capacity towards high-profit HBM and DDR5 products, severely squeezing the capacity for consumer-grade and low-end storage chips, thus widening the supply-demand gap [3][4]. - Storage manufacturers are cautious in their expansion actions following excessive capacity and capital expenditure in the previous cycle, with high-end HBM storage chips facing long cleanroom construction periods and yield ramp-up difficulties, resulting in sustained tight supply in the short term [3][4]. Demand Side: AI Demand Explosion, Super Growth Cycle - The fundamental reason for the current super cycle is the explosive growth in data storage, processing, and retrieval needs driven by the rapid iteration of generative AI technologies [4][28]. - The global consumption of tokens by major AI models in February 2026 is projected to be over ten times that of the same period in 2025, indicating extremely strong demand for computing power and storage [4][28]. - Capital expenditures from the top eight cloud service providers (CSPs) are expected to grow by 25% to approximately $500 billion in 2026, continuing high-intensity investments in computing infrastructure [4][28]. Supply Side: Cautious Expansion Guidance, Extremely Low Manufacturer Inventory - Storage manufacturers, primarily operating under the IDM model, are cautious in their expansion guidance due to significant capital expenditures in the previous cycle [4][78]. - Limited production capacity is being directed towards high-profit HBM and DDR5 products, causing severe pressure on low-end storage chip capacity [4][78]. - Current inventory levels among the three major manufacturers are only 3-5 weeks, at historically low levels, indicating extremely tight supply [4][86]. NAND: AI Demand Driven, Cautious Capacity Expansion - The NAND market is experiencing structural shortages due to the shift of production capacity from NAND and DDR4/DDR3 to higher-margin products, leading to price increases [4][69]. - Major manufacturers are adopting a cautious approach to capacity expansion, focusing on high-end products while avoiding price wars [4][72]. - The NAND market is characterized by a high concentration of major players, with the top five companies holding approximately 90% of the market share [4][73]. DRAM: High-End Demand Explosion, Supply Structure Changes - The demand for high-end DRAM products, particularly HBM and DDR5, has surged due to the explosion of AI computing power, leading to significant price increases [4][51]. - Manufacturers are prioritizing high-margin AI-related products, resulting in a cautious approach to expanding capacity for traditional DRAM products [4][55]. - The overall DRAM market is dominated by three major players, with a combined market share exceeding 91% [4][57].